522 related articles for article (PubMed ID: 25697557)
1. Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients.
Loricera J; Blanco R; Hernández JL; Castañeda S; Mera A; Pérez-Pampín E; Peiró E; Humbría A; Calvo-Alén J; Aurrecoechea E; Narváez J; Sánchez-Andrade A; Vela P; Díez E; Mata C; Lluch P; Moll C; Hernández Í; Calvo-Río V; Ortiz-Sanjuán F; González-Vela C; Pina T; González-Gay MÁ
Semin Arthritis Rheum; 2015 Jun; 44(6):717-23. PubMed ID: 25697557
[TBL] [Abstract][Full Text] [Related]
2. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
[TBL] [Abstract][Full Text] [Related]
3. Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice.
Calderón-Goercke M; Loricera J; Aldasoro V; Castañeda S; Villa I; Humbría A; Moriano C; Romero-Yuste S; Narváez J; Gómez-Arango C; Pérez-Pampín E; Melero R; Becerra-Fernández E; Revenga M; Álvarez-Rivas N; Galisteo C; Sivera F; Olivé-Marqués A; Álvarez Del Buergo M; Marena-Rojas L; Fernández-López C; Navarro F; Raya E; Galindez-Agirregoikoa E; Arca B; Solans-Laqué R; Conesa A; Hidalgo C; Vázquez C; Román-Ivorra JA; Lluch P; Manrique-Arija S; Vela P; De Miguel E; Torres-Martín C; Nieto JC; Ordas-Calvo C; Salgado-Pérez E; Luna-Gomez C; Toyos-Sáenz de Miera FJ; Fernández-Llanio N; García A; Larena C; Palmou-Fontana N; Calvo-Río V; Prieto-Peña D; González-Vela C; Corrales A; Varela-García M; Aurrecoechea E; Dos Santos R; García-Manzanares Á; Ortego N; Fernández S; Ortiz-Sanjuán F; Corteguera M; Hernández JL; González-Gay MÁ; Blanco R
Semin Arthritis Rheum; 2019 Aug; 49(1):126-135. PubMed ID: 30655091
[TBL] [Abstract][Full Text] [Related]
4. Tocilizumab in patients with Takayasu arteritis: a retrospective study and literature review.
Loricera J; Blanco R; Hernández JL; Castañeda S; Humbría A; Ortego N; Bravo B; Freire M; Melchor S; Mínguez M; Salvatierra J; González-Vela C; Calvo-Río V; Santos-Gómez M; Pina T; González-Gay MA
Clin Exp Rheumatol; 2016; 34(3 Suppl 97):S44-53. PubMed ID: 27050507
[TBL] [Abstract][Full Text] [Related]
5. Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients.
Régent A; Redeker S; Deroux A; Kieffer P; Ly KH; Dougados M; Liozon E; Larroche C; Guillevin L; Bouillet L; Espitia O; Costedoat-Chalumeau N; Soubrier M; Brihaye B; Lifermann F; Lefevre G; Puéchal X; Mouthon L; Toussirot E;
J Rheumatol; 2016 Aug; 43(8):1547-52. PubMed ID: 27182063
[TBL] [Abstract][Full Text] [Related]
6. Tocilizumab in refractory aortitis: study on 16 patients and literature review.
Loricera J; Blanco R; Castañeda S; Humbría A; Ortego-Centeno N; Narváez J; Mata C; Melchor S; Aurrecoechea E; Calvo-Alén J; Lluch P; Moll C; Mínguez M; Herrero-Beaumont G; Bravo B; Rubio E; Freire M; Peiró E; González-Vela C; Rueda-Gotor J; Pina T; Palmou-Fontana N; Calvo-Río V; Ortiz-Sanjuán F; González-Gay MÁ
Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S79-89. PubMed ID: 24854377
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations.
Unizony S; McCulley TJ; Spiera R; Pei J; Sidiropoulos PN; Best JH; Birchwood C; Pavlov A; Stone JH
Arthritis Res Ther; 2021 Jan; 23(1):8. PubMed ID: 33407817
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients.
Ortiz-Sanjuán F; Blanco R; Calvo-Rio V; Narvaez J; Rubio Romero E; Olivé A; Castañeda S; Gallego Flores A; Hernández MV; Mata C; Ros Vilamajo I; Sifuentes Giraldo WA; Caracuel MA; Freire M; Gómez Arango C; Llobet J; Manrique Arija S; Marras C; Moll-Tuduri C; Plasencia-Rodriguez C; Roselló R; Urruticoechea A; Velloso-Feijoo ML; Del Blanco J; González-Vela MC; Rueda-Gotor J; Pina T; Loricera J; González-Gay MA
Arthritis Rheumatol; 2014 Jun; 66(6):1659-65. PubMed ID: 24515813
[TBL] [Abstract][Full Text] [Related]
9. Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature.
Macchioni P; Boiardi L; Catanoso M; Pulsatelli L; Pipitone N; Meliconi R; Salvarani C
Semin Arthritis Rheum; 2013 Aug; 43(1):113-8. PubMed ID: 23433960
[TBL] [Abstract][Full Text] [Related]
10. Tocilizumab vs placebo for the treatment of giant cell arteritis with polymyalgia rheumatica symptoms, cranial symptoms or both in a randomized trial.
Spiera R; Unizony SH; Bao M; Luder Y; Han J; Pavlov A; Stone JH
Semin Arthritis Rheum; 2021 Apr; 51(2):469-476. PubMed ID: 33784598
[TBL] [Abstract][Full Text] [Related]
11. Sustained remission after long-term biological therapy in patients with large vessel vasculitis: an analysis of ten cases.
Vinicki JP; García-Vicuña R; Arredondo M; López-Bote JP; García-Vadillo JA; Castañeda S; Álvaro-Gracia JM
Reumatol Clin; 2017; 13(4):210-213. PubMed ID: 27499427
[TBL] [Abstract][Full Text] [Related]
12. Current clinical evidence of tocilizumab for the treatment of ANCA-associated vasculitis: a prospective case series for microscopic polyangiitis in a combination with corticosteroids and literature review.
Sakai R; Kondo T; Kurasawa T; Nishi E; Okuyama A; Chino K; Shibata A; Okada Y; Takei H; Nagasawa H; Amano K
Clin Rheumatol; 2017 Oct; 36(10):2383-2392. PubMed ID: 28733791
[TBL] [Abstract][Full Text] [Related]
13. Tocilizumab in Giant Cell Arteritis: A Real-Life Retrospective Study.
Vitiello G; Orsi Battaglini C; Carli G; Radice A; Matucci A; Vultaggio A; Olianti C; Parronchi P; Maggi E; Cammelli D
Angiology; 2018 Oct; 69(9):763-769. PubMed ID: 29343075
[TBL] [Abstract][Full Text] [Related]
14. Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
Pioro MH
Prim Care; 2018 Jun; 45(2):305-323. PubMed ID: 29759126
[TBL] [Abstract][Full Text] [Related]
15. The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis.
Conticini E; Sota J; Falsetti P; Baldi C; Bardelli M; Bellisai F; Tosi GM; Frediani B; Cantarini L
Mediators Inflamm; 2020; 2020():3203241. PubMed ID: 33061825
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid Dosages and Acute-Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab.
Stone JH; Tuckwell K; Dimonaco S; Klearman M; Aringer M; Blockmans D; Brouwer E; Cid MC; Dasgupta B; Rech J; Salvarani C; Schulze-Koops H; Schett G; Spiera R; Unizony SH; Collinson N
Arthritis Rheumatol; 2019 Aug; 71(8):1329-1338. PubMed ID: 30835950
[TBL] [Abstract][Full Text] [Related]
17. Tocilizumab, an effective treatment for relapsing giant cell arteritis.
Oliveira F; Butendieck RR; Ginsburg WW; Parikh K; Abril A
Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S76-8. PubMed ID: 24854376
[TBL] [Abstract][Full Text] [Related]
18. Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study.
Schmitt C; Brockwell L; Giraudon M; Zucchetto M; Christ L; Bannert B; Daikeler T; Villiger PM
Arthritis Res Ther; 2022 Jun; 24(1):133. PubMed ID: 35659282
[TBL] [Abstract][Full Text] [Related]
19. Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study.
Samson M; Devilliers H; Ly KH; Maurier F; Bienvenu B; Terrier B; Charles P; Guillevin L; Besancenot JF; Liozon E; Fauchais AL; Loffroy R; Binquet C; Audia S; Seror R; Mariette X; Bonnotte B
Eur J Intern Med; 2018 Nov; 57():96-104. PubMed ID: 30054122
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial.
Strand V; Dimonaco S; Tuckwell K; Klearman M; Collinson N; Stone JH
Arthritis Res Ther; 2019 Feb; 21(1):64. PubMed ID: 30786937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
